These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 27755981)

  • 1. Aptamers as a promising approach for the control of parasitic diseases.
    Ospina-Villa JD; Zamorano-Carrillo A; Castañón-Sánchez CA; Ramírez-Moreno E; Marchat LA
    Braz J Infect Dis; 2016; 20(6):610-618. PubMed ID: 27755981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generating aptamers by cell-SELEX for applications in molecular medicine.
    Ye M; Hu J; Peng M; Liu J; Liu J; Liu H; Zhao X; Tan W
    Int J Mol Sci; 2012; 13(3):3341-3353. PubMed ID: 22489154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamers: new arrows to target dendritic cells.
    Ganji A; Varasteh A; Sankian M
    J Drug Target; 2016; 24(1):1-12. PubMed ID: 25950603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of DNA aptamers specific for small therapeutic peptides using a modified SELEX method.
    Lee J; Ryu M; Bae D; Kim HM; Eyun SI; Bae J; Lee K
    J Microbiol; 2022 Jul; 60(7):659-667. PubMed ID: 35731347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamer Selection for Detecting Molecular Target Using Cell-SELEX (Systematic Evolution of Ligands by Exponential Enrichment) Technology.
    Stewart KD; Tan W; Park JY
    Methods Mol Biol; 2019; 2054():223-241. PubMed ID: 31482459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial Intelligence in Aptamer-Target Binding Prediction.
    Chen Z; Hu L; Zhang BT; Lu A; Wang Y; Yu Y; Zhang G
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-specific biomarker discovery by aptamers.
    Ulrich H; Wrenger C
    Cytometry A; 2009 Sep; 75(9):727-33. PubMed ID: 19565638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of whole-cell SELEX methods for the identification of Staphylococcus aureus-specific DNA aptamers.
    Moon J; Kim G; Park SB; Lim J; Mo C
    Sensors (Basel); 2015 Apr; 15(4):8884-97. PubMed ID: 25884791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures.
    Rahimizadeh K; AlShamaileh H; Fratini M; Chakravarthy M; Stephen M; Shigdar S; Veedu RN
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection and Application of Aptamers and Intramers.
    Avci-Adali M
    Adv Exp Med Biol; 2016; 917():241-58. PubMed ID: 27236559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SELEX Modifications and Bioanalytical Techniques for Aptamer-Target Binding Characterization.
    Tan SY; Acquah C; Sidhu A; Ongkudon CM; Yon LS; Danquah MK
    Crit Rev Anal Chem; 2016 Nov; 46(6):521-37. PubMed ID: 26980177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capture-SELEX: Selection Strategy, Aptamer Identification, and Biosensing Application.
    Lam SY; Lau HL; Kwok CK
    Biosensors (Basel); 2022 Dec; 12(12):. PubMed ID: 36551109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving aptamer performance with nucleic acid mimics: de novo and post-SELEX approaches.
    Oliveira R; Pinho E; Sousa AL; DeStefano JJ; Azevedo NF; Almeida C
    Trends Biotechnol; 2022 May; 40(5):549-563. PubMed ID: 34756455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
    Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamers in hematological malignancies and their potential therapeutic implications.
    Ouyang W; Yu Z; Zhao X; Lu S; Wang Z
    Crit Rev Oncol Hematol; 2016 Oct; 106():108-17. PubMed ID: 27637356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamers: selection, modification and application to nervous system diseases.
    Yang Y; Ren X; Schluesener HJ; Zhang Z
    Curr Med Chem; 2011; 18(27):4159-68. PubMed ID: 21838689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamers as Therapeutics.
    Nimjee SM; White RR; Becker RC; Sullenger BA
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():61-79. PubMed ID: 28061688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in cell-SELEX technology for aptamer selection.
    Kaur H
    Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2323-2329. PubMed ID: 30059712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current approaches in SELEX: An update to aptamer selection technology.
    Darmostuk M; Rimpelova S; Gbelcova H; Ruml T
    Biotechnol Adv; 2015 Nov; 33(6 Pt 2):1141-61. PubMed ID: 25708387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.